KR20220025679A - Method for producing fermented apple postbiotics with increased effective component content using lactic acid bacteria - Google Patents
Method for producing fermented apple postbiotics with increased effective component content using lactic acid bacteria Download PDFInfo
- Publication number
- KR20220025679A KR20220025679A KR1020210110688A KR20210110688A KR20220025679A KR 20220025679 A KR20220025679 A KR 20220025679A KR 1020210110688 A KR1020210110688 A KR 1020210110688A KR 20210110688 A KR20210110688 A KR 20210110688A KR 20220025679 A KR20220025679 A KR 20220025679A
- Authority
- KR
- South Korea
- Prior art keywords
- apple
- postbiotics
- fermented
- lactic acid
- acid bacteria
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 19
- 239000004310 lactic acid Substances 0.000 title claims abstract description 12
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 12
- 241000894006 Bacteria Species 0.000 title claims abstract description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 29
- 239000004615 ingredient Substances 0.000 claims abstract description 20
- 238000000855 fermentation Methods 0.000 claims abstract description 16
- 230000004151 fermentation Effects 0.000 claims abstract description 16
- 230000036541 health Effects 0.000 claims abstract description 16
- 229930003935 flavonoid Natural products 0.000 claims abstract description 15
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 15
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 15
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 14
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 14
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 13
- 235000013376 functional food Nutrition 0.000 claims abstract description 13
- 239000002211 L-ascorbic acid Substances 0.000 claims abstract description 12
- 235000000069 L-ascorbic acid Nutrition 0.000 claims abstract description 12
- 241000220225 Malus Species 0.000 claims description 55
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 229940088598 enzyme Drugs 0.000 claims description 13
- 235000015197 apple juice Nutrition 0.000 claims description 12
- 108010059892 Cellulase Proteins 0.000 claims description 11
- 108010059820 Polygalacturonase Proteins 0.000 claims description 11
- 229940106157 cellulase Drugs 0.000 claims description 11
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 10
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 10
- 235000021016 apples Nutrition 0.000 claims description 10
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 235000006708 antioxidants Nutrition 0.000 abstract description 5
- 208000008589 Obesity Diseases 0.000 abstract description 4
- 235000020824 obesity Nutrition 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 235000011430 Malus pumila Nutrition 0.000 description 41
- 235000015103 Malus silvestris Nutrition 0.000 description 41
- 239000000843 powder Substances 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000010421 standard material Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- 241000220296 Malus sp. Species 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000186675 Weissella confusa Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000009369 viticulture Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2116—Flavonoids, isoflavones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2132—Other phenolic compounds, polyphenols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
Abstract
Description
본 발명은 유산균을 이용한 유용성분 함량이 증가된 사과 발효 포스트바이오틱스의 제조방법에 관한 것이다.The present invention relates to a method for producing fermented apple postbiotics with an increased content of useful ingredients using lactic acid bacteria.
유산균은 인간이 이용할 수 있는 가장 유익한 미생물 중의 한 종류로서, 비병원성균으로 인간의 장내에 서식하면서 정장 및 정균작용을 한다. 또한, 당류를 발효해서 다량의 젖산을 생성하고 낮은 pH 및 혐기적인 조건에서도 잘 생육하며 여러 가지 영양물질을 생산하는 특징을 가지고 있다. 유산균에 의해 채소류가 발효되면 독특한 향과 맛을 내게 되어 관능적 특성이 향상되고, 유기산에 의하여 비타민 C와 여러 생리활성물질이 잘 보존되며, 초기 재료에는 거의 존재하지 않았던 비타민 B12와 비타민 K가 생합성되어 부패균과 병원성균의 성장과 증식을 저해하여 위생적인 식품이 되는 등의 장점을 가지고 있는 것으로 알려져 있다.Lactobacillus is one of the most beneficial microorganisms available to humans, and is a non-pathogenic bacteria that live in the human intestine and perform intestinal and bacteriostatic actions. In addition, it has the characteristics of producing a large amount of lactic acid by fermenting sugars, growing well under low pH and anaerobic conditions, and producing various nutrients. When vegetables are fermented by lactic acid bacteria, their unique flavor and taste are improved, and the sensory properties are improved, and vitamin C and various physiologically active substances are well preserved by organic acids. It is known to have the advantage of becoming a hygienic food by inhibiting the growth and proliferation of putrefactive and pathogenic bacteria.
사과는 장미과(Rosaceae) 사과나무속(Malus sp.)에 속하는 다년생 식물인 사과나무의 열매로, 단백질과 지방은 비교적 적으며, 비타민 A, 비타민 C 및 무기염류의 함량이 높은 알칼리성 과실이다. 사과에는 수용성 식이섬유인 펙틴이 다량 함유되어 있는데, 이는 혈중 콜레스테롤을 낮추고, 혈당의 급격한 상승을 억제시키며, 장내에서 갈락투론산을 분비시켜 지방산 합성을 억제하는 작용을 나타낸다. 또한, 사과의 붉은색 과피에는 안토시아닌과 같은 폴리페놀계 항산화 물질이 포함되어 있다고 알려져 있다. 이와 같이, 사과는 혈압강하 작용, 동맥경화 예방, 당뇨병 예방, 항산화 작용, 식이섬유에 의한 항암작용 및 비만 예방, 면역기능 증진에 효과가 뛰어날 뿐만 아니라, 건강과 피부미용에도 좋아 높은 소비량을 보이고 있다. 그러나, 저장성의 한계로 인하여 사과가 가지고 있는 신선한 향미를 장기간 보존하기가 어렵고, 계절적인 한계로 인하여 항상 섭취하기에는 불편한 점이 있다.Apples are fruits of apple trees, which are perennial plants belonging to the genus Malus sp. of the Rosaceae family, and are alkaline fruits with relatively little protein and fat, and high content of vitamin A, vitamin C and inorganic salts. Apples contain a large amount of pectin, a water-soluble dietary fiber, which lowers blood cholesterol, suppresses rapid rise in blood sugar, and inhibits fatty acid synthesis by secreting galacturonic acid in the intestine. In addition, it is known that the red skin of apples contains polyphenol-based antioxidants such as anthocyanins. As such, apples are not only effective in lowering blood pressure, preventing arteriosclerosis, preventing diabetes, antioxidant activity, anti-cancer activity and obesity prevention by dietary fiber, and enhancing immune function, but also show high consumption because they are good for health and skin care. . However, it is difficult to preserve the fresh flavor of apples for a long time due to the limitation of storage, and it is inconvenient to always consume it due to the seasonal limitation.
한편, 한국등록특허 제1941967호에는 '칼슘 이온이 다량 함유된 사과발효물'에 대해 개시하고 있으며, 한국등록특허 제1994172호에는 '웨이셀라 콘퓨사 SRCM100892 균주를 이용한 사과발효음료 및 이를 이용한 젤리의 제조방법'에 대해 개시하고 있다. 하지만, 본 발명의 '유산균을 이용한 유용성분 함량이 증가된 사과 발효 포스트바이오틱스의 제조방법'에 대해서는 아직까지 개시된 바가 없다.On the other hand, Korean Patent No. 1941967 discloses 'a fermented apple containing a large amount of calcium ions', and Korean Patent No. 1994172 discloses 'Apple fermented beverage using Weissella confusa SRCM100892 strain and jelly using the same. manufacturing method' is disclosed. However, the 'method for producing fermented apple postbiotics with an increased content of useful ingredients using lactic acid bacteria' of the present invention has not yet been disclosed.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 사과 액에 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)를 처리한 후 락토바실러스 플랜타룸 CBG-C21(Lactobacillus plantarum CBG-C21) 균주로 발효하고 동결건조하여 사과 발효 포스트바이오틱스 분말을 제조하였고, 효소 처리 및 발효하지 않은 사과 분말에 비해 상기 사과 발효 포스트바이오틱스 분말의 총 폴리페놀(polyphenol), 총 플라보노이드(flavonoid) 및 L-아스코르브산(L-ascorbic acid) 함량이 현저하게 증가하는 것을 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above needs, and the present inventors treated apple juice with cellulase and polygalacturonase, and then Lactobacillus plantarum CBG-C21 ( Lactobacillus plantarum CBG-C21) ) strain and freeze-drying to prepare apple fermented postbiotic powder, and compared to the enzyme-treated and unfermented apple powder, the total polyphenols, total flavonoids, and L of the apple fermented postbiotic powder - By confirming that the content of ascorbic acid significantly increased, the present invention was completed.
상기 과제를 해결하기 위하여, 본 발명은 1) 사과에 효소를 처리하는 단계; 및 2) 상기 단계 1)에서 효소 처리한 사과에 유산균을 접종하여 발효하는 단계;를 포함하는 유용성분 함량이 증가된 사과 발효 포스트바이오틱스의 제조방법을 제공한다.In order to solve the above problems, the present invention comprises the steps of: 1) treating an apple with an enzyme; and 2) inoculating lactic acid bacteria into the apples treated with the enzyme in step 1) and fermenting them.
또한, 본 발명은 상기 제조방법으로 제조된 유용성분 함량이 증가된 사과 발효 포스트바이오틱스를 제공한다.In addition, the present invention provides an apple fermented postbiotics with an increased content of useful ingredients prepared by the above manufacturing method.
또한, 본 발명은 상기 유용성분 함량이 증가된 사과 발효 포스트바이오틱스를 포함하는 건강기능식품을 제공한다.In addition, the present invention provides a health functional food comprising apple fermented postbiotics having an increased content of the useful ingredients.
본 발명에 따른 제조방법을 이용하면 총 폴리페놀, 총 플라보노이드 및 L-아스코르브산 함량이 증가된 사과 발효 포스트바이오틱스를 제공할 수 있고, 항산화, 비만 예방, 면역 증진 등을 위한 건강기능식품 제조에 유용하게 이용할 수 있다.By using the manufacturing method according to the present invention, it is possible to provide fermented apple postbiotics with an increased content of total polyphenols, total flavonoids and L-ascorbic acid, and it is used in the manufacture of health functional foods for antioxidant, obesity prevention, immunity enhancement, etc. It can be useful.
도 1은 본 발명의 사과 발효 포스트바이오틱스 내의 총 폴리페놀 함량을 나타낸 것이다.
도 2는 본 발명의 사과 발효 포스트바이오틱스 내의 총 플라보노이드 함량을 나타낸 것이다.
도 3은 본 발명의 사과 발효 포스트바이오틱스 내의 L-아스코르브산 함량을 나타낸 것이다.1 shows the total polyphenol content in the apple fermentation postbiotics of the present invention.
Figure 2 shows the total flavonoid content in the apple fermentation postbiotics of the present invention.
3 shows the L-ascorbic acid content in the apple fermentation postbiotics of the present invention.
본 발명의 목적을 달성하기 위하여, 본 발명은 In order to achieve the object of the present invention, the present invention
1) 사과에 효소를 처리하는 단계; 및1) treating apples with enzymes; and
2) 상기 단계 1)에서 효소 처리한 사과에 유산균을 접종하여 발효하는 단계;를 포함하는 유용성분 함량이 증가된 사과 발효 포스트바이오틱스(postbiotics)의 제조방법을 제공한다.2) Inoculating the lactic acid bacteria in the enzyme-treated apple in step 1) and fermenting the apple.
본 명세서에서 용어 "포스트바이오틱스"는 건강에 유익한 미생물인 프로바이오틱스(probiotics)가 프리바이오틱스(prebiotics)를 영양원으로 이용하여 생성한 대사 또는 발효 산물을 의미한다. 포스트바이오틱스의 대표적인 형태로는 프로바이오틱스를 특정한 방법으로 가공 처리한 사균체 또는 발효물 등이 있다. As used herein, the term “postbiotics” refers to metabolic or fermentation products produced by probiotics, which are microorganisms beneficial to health, using prebiotics as a nutrient source. As a representative form of postbiotics, there are dead cells or fermented products processed by a specific method of probiotics.
본 발명에서 상기 "사과 발효 포스트바이오틱스"는 "사과 유산균 발효물"을 의미한다.In the present invention, the "apple fermentation postbiotics" means "apple lactic acid bacteria fermented product".
본 발명의 유용성분 함량이 증가된 사과 발효 포스트바이오틱스의 제조방법에서, 상기 사과는 사과 추출물, 즙, 농축액 또는 분말과 같은 다양한 형태일 수 있으며, 바람직하게는 사과 농축액 분말에 물을 혼합하여 제조한 사과액일 수 있으나, 이에 제한되지 않는다.In the method for producing fermented apple postbiotics having an increased content of useful ingredients of the present invention, the apple may be in various forms such as apple extract, juice, concentrate or powder, and preferably prepared by mixing apple concentrate powder with water. It may be one apple juice, but is not limited thereto.
또한, 상기 효소는 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)일 수 있으나, 이에 제한되지 않는다. 상기 효소는 동시에 또는 순차적으로 처리될 수 있으나, 이에 제한되지 않는다.In addition, the enzyme may be cellulase (cellulase) and polygalacturonase (polygalacturonase), but is not limited thereto. The enzymes may be treated simultaneously or sequentially, but is not limited thereto.
또한, 상기 유산균은 락토바실러스 플랜타룸(Lactobacillus plantarum) 균주일 수 있으며, 바람직하게는 기탁번호가 KACC92083P인 락토바실러스 플랜타룸 CBG-C21(Lactobacillus plantarum CBG-C21) 균주일 수 있으나, 이에 제한되지 않는다.In addition, the lactic acid bacteria may be a Lactobacillus plantarum strain, preferably a Lactobacillus plantarum CBG-C21 strain having an accession number of KACC92083P, but is not limited thereto.
또한, 상기 발효는 32~42℃에서 18~28시간 동안 수행할 수 있으며, 바람직하게는 37℃에서 23시간 동안 수행한 것일 수 있으나, 이에 제한되지 않는다.In addition, the fermentation may be performed at 32-42° C. for 18-28 hours, preferably at 37° C. for 23 hours, but is not limited thereto.
또한, 상기 유용성분은 총 폴리페놀(polyphenol), 총 플라보노이드(flavonoid) 및 L-아스코르브산(L-ascorbic acid)일 수 있으나, 이에 제한되지 않는다.In addition, the useful component may be total polyphenols (polyphenol), total flavonoids (flavonoid) and L-ascorbic acid (L-ascorbic acid), but is not limited thereto.
본 발명에 따른 상기 제조방법은 바람직하게는,The manufacturing method according to the present invention is preferably,
1) 25~35%(w/v) 사과액에 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)를 처리하고 50~60℃에서 1.5~2.5시간 동안 반응시키는 단계; 및 1) treating 25-35% (w/v) apple juice with cellulase and polygalacturonase and reacting at 50-60° C. for 1.5-2.5 hours; and
2) 상기 단계 1)에서 셀룰라아제 및 폴리갈락투로나아제를 처리한 사과액에 3.0×107~3.0×109 CFU/㎖의 락토바실러스 플랜타룸 CBG-C21 균주를 접종하여 32~42℃에서 18~28시간 동안 발효하는 단계;를 포함할 수 있으며, 가장 바람직하게는,2) Inoculate the Lactobacillus plantarum CBG-C21 strain at 3.0×10 7 to 3.0×10 9 CFU/ml into the apple juice treated with cellulase and polygalacturonase in step 1) at 32 to 42° C. Fermentation for 18 to 28 hours; may include, and most preferably,
1) 30%(w/v) 사과액에 0.1%(w/v) 셀룰라아제 및 0.1%(w/v) 폴리갈락투로나아제를 처리하고 55℃에서 2시간 동안 반응시키는 단계; 및 1) 30% (w/v) apple juice is treated with 0.1% (w/v) cellulase and 0.1% (w/v) polygalacturonase and reacted at 55° C. for 2 hours; and
2) 상기 단계 1)에서 셀룰라아제 및 폴리갈락투로나아제를 처리한 사과액에 3.0×108 CFU/㎖의 락토바실러스 플랜타룸 CBG-C21 균주를 접종하여 37℃에서 23시간 동안 발효하는 단계;를 포함할 수 있으나, 이에 제한되지 않는다.2) inoculating the Lactobacillus plantarum CBG-C21 strain at 3.0×10 8 CFU/ml into the apple juice treated with cellulase and polygalacturonase in step 1) and fermenting at 37° C. for 23 hours; may include, but is not limited thereto.
또한, 본 발명에 따른 제조방법은 상기 단계 2)의 발효물을 동결건조하는 단계를 추가로 포함할 수 있으나, 이에 제한되지 않는다.In addition, the manufacturing method according to the present invention may further include the step of freeze-drying the fermented product of step 2), but is not limited thereto.
본 발명은 또한, 상기 제조방법으로 제조된 유용성분 함량이 증가된 사과 발효 포스트바이오틱스를 제공한다. 상기 유용성분은 전술한 바와 같다.The present invention also provides an apple fermented postbiotics having an increased content of useful ingredients prepared by the above manufacturing method. The useful ingredients are the same as described above.
상기 포스트바이오틱스는 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽, 발포정 및 음료 중에서 선택된 어느 하나의 제형으로 제조될 수 있으나, 이에 제한되지 않는다.The postbiotics may be prepared in any one formulation selected from powder, granule, pill, tablet, capsule, candy, syrup, effervescent tablet and beverage, but is not limited thereto.
본 발명은 또한, 상기 유용성분 함량이 증가된 사과 발효 포스트바이오틱스를 포함하는 건강기능식품을 제공한다. 상기 유용성분은 전술한 바와 같다.The present invention also provides a health functional food comprising apple fermented postbiotics having an increased content of the useful ingredients. The useful ingredients are the same as described above.
상기 건강기능식품의 종류에는 특별한 제한은 없다. 상기 사과 발효 포스트바이오틱스를 함유하는 건강기능식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 떡류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강기능식품을 모두 포함한다.There is no particular limitation on the type of the health functional food. Examples of health functional foods containing the apple fermented postbiotics include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, rice cakes, dairy products including ice cream, various soups, There are beverages, teas, drinks, alcoholic beverages, and vitamin complexes, and includes all health functional foods in the ordinary sense.
본 발명에 따른 사과 발효 포스트바이오틱스는 효소 처리 및 발효하지 않은 사과에 비해 총 폴리페놀, 총 플라보노이드 및 L-아스코르브산의 함량이 증가된 것으로, 상기 유용성분들의 항산화, 비만 예방, 면역기능 증진 기능 등을 이용하여 다양한 건강기능식품을 제조할 수 있다.The apple fermented postbiotics according to the present invention has an increased content of total polyphenols, total flavonoids and L-ascorbic acid compared to apples without enzyme treatment and fermentation, and the antioxidant, obesity prevention, and immune function enhancement functions of the useful ingredients Various health functional foods can be manufactured using the
상기 건강기능식품은 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽, 발포정 및 음료 중에서 선택된 어느 하나의 제형으로 제조될 수 있으나, 이에 제한되지 않는다.The health functional food may be prepared in any one formulation selected from powder, granule, pill, tablet, capsule, candy, syrup, effervescent tablet and beverage, but is not limited thereto.
본 발명의 사과 발효 포스트바이오틱스를 식품첨가물로 사용하는 경우, 상기 사과 발효 포스트바이오틱스를 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분은 그의 사용 목적에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시에 본 발명의 사과 발효 포스트바이오틱스는 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양의로 첨가된다. 그러나 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 안전성 면에서 아무런 문제가 없는 범위의 양으로 사용될 수 있다.When the fermented apple postbiotic of the present invention is used as a food additive, the fermented apple postbiotic may be added as it is or used together with other foods or food ingredients, and may be appropriately used according to a conventional method. The active ingredient may be appropriately used depending on the purpose of its use. In general, in the production of food or beverage, the apple fermented postbiotics of the present invention are added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less, based on the raw material. However, in the case of long-term intake for the purpose of health control, it can be used in an amount within a range that does not cause any problems in terms of safety.
본 발명의 건강기능식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다. 상기 건강기능식품 조성물 외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. The health functional food of the present invention includes ingredients commonly added during food production, for example, proteins, carbohydrates, fats, nutrients and seasonings. For example, when manufactured as a drink, natural carbohydrates or flavoring agents may be included as additional ingredients in addition to the active ingredient. The natural carbohydrates include monosaccharides (eg, glucose, fructose, etc.), disaccharides (eg, maltose, sucrose, etc.), oligosaccharides, polysaccharides (eg, dextrin, cyclodextrin, etc.) or sugar alcohols (eg, , xylitol, sorbitol, erythritol, etc.) is preferable. As the flavoring agent, natural flavoring agents (eg, taumartin, stevia extract, etc.) and synthetic flavoring agents (eg, saccharin, aspartame, etc.) may be used. In addition to the above health functional food composition, various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonic acid It may further contain a carbonation agent and the like used in beverages.
상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 100 중량부에 대하여, 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.Although the proportion of the added component is not very important, it is generally selected in the range of 0.01 to 0.1 parts by weight based on 100 parts by weight of the health functional food of the present invention.
이하, 본 발명의 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, an embodiment of the present invention will be described in detail. However, the following examples are only illustrative of the present invention, and the content of the present invention is not limited to the following examples.
제조예 1. 사과 발효 포스트바이오틱스 제조Preparation Example 1. Preparation of Apple Fermented Postbiotics
90.97 g의 사과 농축액 분말을 칭량하여 210 ㎖의 정제수와 혼합하여 30%(w/v)의 사과액을 제조하였다. 이후, pH 7.0으로 보정하고 덱스트린을 첨가한 후, 동결건조하고 분말화하여 대조군(사과 분말)으로 이용하였다. 90.97 g of apple concentrate powder was weighed and mixed with 210 ml of purified water to prepare 30% (w/v) apple juice. Thereafter, the pH was corrected to 7.0 and dextrin was added, lyophilized and powdered, and used as a control (apple powder).
사과의 발효를 위하여 락토바실러스 플랜타룸(Lactobacillus plantarum) CBG-C21 균주(기탁번호: KACC92083P)를 24시간 동안 배양하여 6.0×109 CFU/㎖의 균주 배양액을 준비하였다. 상기 사과액에 0.1%(w/v)의 셀룰라아제(cellulase) 및 0.1%(w/v)의 폴리갈락투로나아제(polygalacturonase)를 처리하여 55℃에서 2시간 동안 반응시킨 후, 2%(w/v) 포도당 및 1%(w/v) 카제인 펩톤을 첨가하여 121℃에서 15분간 가압멸균하였다. 이후, 효소 처리한 사과액에 락토바실러스 플랜타룸 CBG-C21 균주 배양액 5%(3.0×108 CFU/㎖)를 접종하여 37℃에서 23시간 동안 정치배양하여 발효를 수행하였다. 발효가 완료된 사과 발효액에 덱스트린을 첨가한 후, 동결건조하고 분말화하여 사과 발효 포스트바이오틱스 분말을 제조하였다. For the fermentation of apples, Lactobacillus plantarum CBG-C21 strain (Accession No.: KACC92083P) was cultured for 24 hours to prepare a strain culture solution of 6.0×10 9 CFU/ml. The apple juice was treated with 0.1% (w/v) cellulase and 0.1% (w/v) polygalacturonase and reacted at 55° C. for 2 hours, followed by 2% ( w/v) glucose and 1% (w/v) casein peptone were added and autoclaved at 121° C. for 15 minutes. Thereafter, the enzyme-treated apple juice was inoculated with 5% (3.0×10 8 CFU/ml) of the Lactobacillus plantarum CBG-C21 strain, and cultured at 37° C. for 23 hours to perform fermentation. After dextrin was added to the fermented apple juice after fermentation, it was freeze-dried and powdered to prepare an apple fermented postbiotic powder.
실시예 1. 유용성분 함량 분석Example 1. Analysis of the content of useful ingredients
상기 제조예 1의 사과 분말 및 사과 발효 포스트바이오틱스 분말을 대상으로 항산화 관련 유용성분인 총 폴리페놀(polyphenol), 총 플라보노이드(flavonoid) 및 L-아스코르브산(L-ascorbic acid) 함량을 측정하였다. 총 폴리페놀 함량 측정은 싱글톤 및 로시의 방법(Singleton, V. and Rossi, J et al., 1965, American Journal of Enology and Viticulture. 16:144-158)을 일부 변형하여 측정하였다. 시료 용액 및 갈산(gallic acid) 표준물질(20, 40, 60, 80, 100 mg/L) 1 ㎖을 9 ㎖의 3차 증류수가 들어 있는 25 ㎖ 정량 플라스크에 각각 넣고, 페놀용액(Folin-ciocalteu's phenol reagent) 1 ㎖을 첨가하였다. 5분 후 7% Na2CO3 용액 10 ㎖을 가하여 충분히 교반한 다음 3차 증류수로 25 ㎖을 채워서 혼합하여 23℃에서 90분간 반응시킨 후 750 nm에서 blank를 대조군으로 하여 흡광도를 측정하였다. 이때, 표준 검량 곡선은 표준 물질로서 갈산을 일정 농도로 하여 상기와 동일한 방법으로 측정하여 획득하였으며, 시료의 흡광도를 표준 검량 곡선에 대입하여 총 페놀 함량을 ㎍/g로 나타내었다Total polyphenol, total flavonoid, and L-ascorbic acid content, which are useful antioxidant-related ingredients, were measured for the apple powder and apple fermented postbiotic powder of Preparation Example 1. The total polyphenol content was measured with some modifications of the Singleton and Rossi method (Singleton, V. and Rossi, J et al., 1965, American Journal of Enology and Viticulture. 16:144-158). Put 1 ml of the sample solution and gallic acid standard (20, 40, 60, 80, 100 mg/L) into a 25 ml quantitative flask containing 9 ml of tertiary distilled water, respectively, and phenol solution (Folin-ciocalteu's) phenol reagent) 1 ㎖ was added. After 5 minutes, 10 ml of a 7% Na 2 CO 3 solution was added and sufficiently stirred. Then, 25 ml of tertiary distilled water was filled, mixed, and reacted at 23° C. for 90 minutes. Absorbance was measured at 750 nm using a blank as a control. At this time, the standard calibration curve was obtained by measuring in the same manner as above using gallic acid as a standard material at a constant concentration, and the absorbance of the sample was substituted into the standard calibration curve to express the total phenol content in μg/g.
총 플라보노이드 함량은 지센의 방법(Zhishen J. et al., 1999, Food Chemistry. 64:555-559)을 변형하여 측정하였다. 시료 용액 및 퀘세틴(quercetin) 표준물질(20, 40, 60, 80, 100 mg/L) 1 ㎖을 4 ㎖의 3차 증류수가 들어있는 10 ㎖ 정량 플라스크에 각각 넣고 제로 타임에 5% NaNO2를 0.3 ㎖ 첨가하여 충분히 교반하였다. 5분 후 10% AlCl3을 0.3 ㎖ 넣어주고 6분이 되었을 때 1M NaOH를 2 ㎖ 첨가하고 즉시 3차 증류수를 2.4 ㎖ 첨가하여 완전히 혼합한 후 실온에서 1분간 반응시킨 다음 UV/Vis Spectrometer를 이용하여 510 nm에서 blank를 대조군으로 하여 각 용액의 흡광도를 측정하였다. 이때, 총 플라보노이드 함량은 표준 물질로서 퀘세틴을 일정 농도로 하여 상기와 동일한 방법으로 측정하여 획득하였으며, 시료의 흡광도를 표준 검량 곡선에 대입하여 총 플라보노이드 함량을 ㎍/g로 나타내었다.Total flavonoid content was determined by modifying Zhishen's method (Zhishen J. et al., 1999, Food Chemistry. 64:555-559). Add 1 ml of the sample solution and quercetin standard (20, 40, 60, 80, 100 mg/L) to a 10 ml quantitative flask containing 4 ml of tertiary distilled water, respectively, and at zero time, 5% NaNO 2 0.3 ml was added, and the mixture was sufficiently stirred. After 5 minutes, 0.3 mL of 10% AlCl 3 was added, and at 6 minutes, 2 mL of 1M NaOH was added, and immediately, 2.4 mL of tertiary distilled water was added, mixed thoroughly, and reacted at room temperature for 1 minute, then using UV/Vis Spectrometer The absorbance of each solution was measured at 510 nm using the blank as a control. At this time, the total flavonoid content was obtained by measuring in the same way as above using a certain concentration of querycetin as a standard material, and substituting the absorbance of the sample into the standard calibration curve to express the total flavonoid content in μg/g.
L-아스코르브산 함량은 Megazyme assay kit(Megazyme Ltd.)를 이용하여 측정하였다. 구체적으로, 100 mg의 시료에 3%(w/v) 메타인산(metaphosphoric acid) 및 10 mM EDTA(ethylenediaminetetraacetic acid)를 첨가하여 상온에서 60분간 균질화하고 10분간 원심분리한 후 수득한 상등액을 여과하여 사용하였다. 10 ㎕의 여과한 상등액에 152 ㎕의 3차 증류수 및 버퍼 1을 혼합하고 3분 후 MTT[3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide] 버퍼 2를 넣고 3분간 반응시켰으며, 분광광도계를 이용하여 578 nm에서 1차 흡광도(A1)를 측정하고, PMS(5-methylphenazinium methyl sulfate) 버퍼를 넣고 8분 동안 반응시킨 후 578 nm에서 2차 흡광도(A2)를 측정하였다. The L-ascorbic acid content was measured using a Megazyme assay kit (Megazyme Ltd.). Specifically, 3% (w/v) metaphosphoric acid and 10 mM EDTA (ethylenediaminetetraacetic acid) were added to a 100 mg sample, homogenized at room temperature for 60 minutes, centrifuged for 10 minutes, and the obtained supernatant was filtered. was used. 152 μl of tertiary distilled water and buffer 1 were mixed with 10 μl of the filtered supernatant, and after 3 minutes, MTT[3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide] buffer 2 was added and reacted for 3 minutes The primary absorbance (A1) was measured at 578 nm using a spectrophotometer, and a PMS (5-methylphenazinium methyl sulfate) buffer was added and reacted for 8 minutes. Secondary absorbance (A2) was measured at 578 nm. .
그 결과, 하기 표 1에 개시한 바와 같이 효소 처리 및 발효하지 않은 사과 분말에 비해 사과 발효 포스트바이오틱스 분말 내의 총 폴리페놀, 총 플라보노이드 및 L-아스코르브산 함량이 유의하게 증가한 것을 확인하였다(도 1 내지 도 3).As a result, as shown in Table 1 below, it was confirmed that the contents of total polyphenols, total flavonoids and L-ascorbic acid in the apple fermented postbiotic powder were significantly increased compared to the apple powder without enzyme treatment and fermentation (Fig. 1). to 3).
포스트바이오틱스 분말apple fermentation
Postbiotics Powder
Claims (7)
2) 상기 단계 1)에서 효소 처리한 사과에 유산균을 접종하여 발효하는 단계;를 포함하는 유용성분 함량이 증가된 사과 발효 포스트바이오틱스(postbiotics)의 제조방법.1) treating apples with enzymes; and
2) Inoculating the lactic acid bacteria in the enzyme-treated apple in step 1) and fermenting the apple.
1) 사과액에 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)를 처리하고 50~60℃에서 1.5~2.5시간 동안 반응시키는 단계; 및
2) 상기 단계 1)에서 셀룰라아제 및 폴리갈락투로나아제를 처리한 사과액에 기탁번호가 KACC92083P인 락토바실러스 플랜타룸 CBG-C21 균주를 접종하여 32~42℃에서 18~28시간 동안 발효하는 단계;를 포함하는, 총 폴리페놀(polyphenol), 총 플라보노이드(flavonoid) 및 L-아스코르브산(L-ascorbic acid)의 유용성분 함량이 증가된 사과 발효 포스트바이오틱스의 제조방법.The method of claim 1,
1) treating apple juice with cellulase and polygalacturonase and reacting at 50 to 60° C. for 1.5 to 2.5 hours; and
2) Inoculating the Lactobacillus plantarum CBG-C21 strain having an accession number of KACC92083P into the apple juice treated with cellulase and polygalacturonase in step 1) and fermenting it at 32-42°C for 18-28 hours. ; A method for producing an apple fermentation postbiotic with an increased content of useful components of total polyphenols, total flavonoids, and L-ascorbic acid, including.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200106048 | 2020-08-24 | ||
KR20200106048 | 2020-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220025679A true KR20220025679A (en) | 2022-03-03 |
Family
ID=80818928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210110688A KR20220025679A (en) | 2020-08-24 | 2021-08-23 | Method for producing fermented apple postbiotics with increased effective component content using lactic acid bacteria |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220025679A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116270826A (en) * | 2023-03-09 | 2023-06-23 | 中国农业科学院麻类研究所 | Method for improving activity of rose in reducing blood sugar and blood fat and application |
KR20240017266A (en) | 2022-07-29 | 2024-02-07 | 씨제이제일제당 (주) | Fermented apple composition |
KR20240017267A (en) | 2022-07-29 | 2024-02-07 | 씨제이제일제당 (주) | Fermented apple composition |
-
2021
- 2021-08-23 KR KR1020210110688A patent/KR20220025679A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240017266A (en) | 2022-07-29 | 2024-02-07 | 씨제이제일제당 (주) | Fermented apple composition |
KR20240017267A (en) | 2022-07-29 | 2024-02-07 | 씨제이제일제당 (주) | Fermented apple composition |
CN116270826A (en) * | 2023-03-09 | 2023-06-23 | 中国农业科学院麻类研究所 | Method for improving activity of rose in reducing blood sugar and blood fat and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20220025679A (en) | Method for producing fermented apple postbiotics with increased effective component content using lactic acid bacteria | |
US8691220B2 (en) | Powdery malted rice extract composition | |
KR101365917B1 (en) | Making method for fermentation beverage of rubus coreanus | |
KR101467837B1 (en) | Manufacturing method of fermented red ginseng extract with enhanced ginsenosides Rg3 and antioxidant activity | |
KR20160096967A (en) | Composition for preventing respiratorydisease, immune-enhancing, anti-obesity containing fermented Platycodon grandiflorum | |
KR20220025680A (en) | Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria | |
KR20170141952A (en) | Method for manufacturing old antler and Auricularia judae fermented solution by lactic acid fermentation and food composition for improving inflammation comprising the fermented solution | |
Chen et al. | Traditional food, modern food and nutritional value of Sea buckthorn (Hippophae rhamnoides L.): A review | |
KR102394733B1 (en) | Method for producing fermented spinach and fermented soybean with increased effective component content using lactic acid bacteria | |
KR101962570B1 (en) | Improve anti-oxidant beverage composition of containing Aronia fermented product by lactic acid and preparation method of the same | |
KR20220025681A (en) | Method for producing fermented cranberry postbiotics with increased effective component content using lactic acid bacteria | |
KR20220025678A (en) | Method for producing fermented barley sprout postbiotics with increased effective component content using lactic acid bacteria | |
KR20220136107A (en) | Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same | |
KR20170120264A (en) | Fermented chestnut puree of probiotic lactic acid bacteria and foods composition, medicinal composition including the same | |
KR20200145127A (en) | Composition and method for yogurt with enhanced GABA using barley and yogurt produced by the same | |
KR20200078171A (en) | The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K, Rd and Rd3 using β-glucosidase and lactic acid bacteria | |
JP2009240308A (en) | METHOD FOR PRODUCING MATERIAL CONTAINING Gamma-AMINOBUTYRIC ACID IN HIGH CONTENT | |
KR102102995B1 (en) | Manufacturing method of vinegar using black rice and sugar fermented liquor and vinegar manufactured thereby | |
KR20140095132A (en) | fermented corni fructus composition with antioxidant activity and method of making the same | |
KR20160069119A (en) | Fermentation Process of a Garlic Using New Strain of Bacillus subtilis | |
KR20150131483A (en) | Method for producing Platycodon grandiflorus fermented broth with enhanced antioxidant activity and inhibition activity of alpha-glucosidase | |
KR20190051275A (en) | Fermentation method of lactic acid bacteria using fruit of Prunus sp. and its use | |
KR20140080756A (en) | Method for producing fermented Gastrodiae rhizoma with increased functionality using mixed fermentation strain and fermented Gastrodiae rhizoma produced by the method | |
KR102224926B1 (en) | Lactobacillus sakei NY518 strain, culture thereof and enteric health improving functional food composition comprising the same | |
KR102346162B1 (en) | Functional fermented material of auricularia auricula-judae by mixed fermentation and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |